Abstract

Opinion

Proposal for the elimination of allergies

James F Walles*

Published: 11 July, 2019 | Volume 3 - Issue 1 | Pages: 019-019

A man I knew had an extreme allergy to poison ivy when he was a child. When he was about four-teen, he was hanging out with a group of his friends who dared him to eat some poison ivy. He did, and never got poison ivy again. Presumably, the ingestion of the allergen led to the development of immunity.

This might be a pathway to eliminating allergies–ingest the allergen. For example, cutting up poison ivy leaves into small pieces and crushing them with a mortar and pestle should lead to some juice in the mortar. Allow that to evaporate and have a test subject ingest the resultant powder, which, like pollen, etc., could be compressed into a pill. Wait 48 hours, and then see if the subject gets a rash when a small, unimportant area of the body is exposed to poison ivy leaves–and have Ivy-Dry handy. This could be a way to eliminate allergies–ingestion of the allergen.

Read Full Article HTML DOI: 10.29328/journal.icci.1001010 Cite this Article Read Full Article PDF

References

Similar Articles

Recently Viewed

  • Challenge of polymers for biosimilar products packaging
    Anupam Chanda* Anupam Chanda*. Challenge of polymers for biosimilar products packaging. Arch Biotechnol Biomed. 2021: doi: 10.29328/journal.abb.1001029; 5: 057-058
  • Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC
    Tobias R Overbeck*, Stefan HP Wenleder*, Bernhard C Danner, Wolfgang Körber, Karin Toepelt, Bernhard Hemmerlein, Christina Perske, Markus Falk, Markus Tiemann, Claudia Tomala, Elke Stitz and Frank Griesinger Tobias R Overbeck*,Stefan HP Wenleder*,Bernhard C Danner,Wolfgang Körber, Karin Toepelt,Bernhard Hemmerlein, Christina Perske,Markus Falk,Markus Tiemann,Claudia Tomala,Elke Stitz,Frank Griesinger. Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC. J Pulmonol Respir Res. 2021: doi: 10.29328/journal.jprr.1001018; 5: 001-018
  • Seasonal change and COVID-19: Will the harmattan season lead to an increase in COVID-19 cases in Nigeria?
    Prince Chiagozie Ekoh* Prince Chiagozie Ekoh*. Seasonal change and COVID-19: Will the harmattan season lead to an increase in COVID-19 cases in Nigeria?. J Pulmonol Respir Res. 2020: doi: 10.29328/journal.jprr.1001017; 4: 021-022
  • Mestranol moieties clicked to Zn(II)phthalocyanine for controllable photosensitized oxidation of cholesterol
    Vanya Mantareva*, Meliha Syuleyman, Adriana Slavova-Kazakova, Ivan Angelov and Mahmut Durmus Vanya Mantareva*,Meliha Syuleyman,Adriana Slavova-Kazakova,Ivan Angelov,Mahmut Durmus. Mestranol moieties clicked to Zn(II)phthalocyanine for controllable photosensitized oxidation of cholesterol. Arch Biotechnol Biomed. 2021: doi: 10.29328/journal.abb.1001027; 5: 041-048
  • Spontaneous pneumomediastinum associated with COVID-19: Rare complication of 2020 pandemic
    Arnaldo A Nieves-Ortiz*, Vanessa Fonseca-Ferrer, Kyomara Hernández-Moya, Keren Mendez Ramirez, Jose Ayala-Rivera, Marangely Delgado, Juan Garcia-Puebla, Rosangela Fernández-Medero and Ricardo Fernandez-Gonzalez Arnaldo A Nieves-Ortiz*,Vanessa Fonseca-Ferrer, Kyomara Hernández-Moya,Keren Mendez Ramirez,Jose Ayala-Rivera,Marangely Delgado, Juan Garcia-Puebla,Rosangela Fernández-Medero,Ricardo Fernandez-Gonzalez. Spontaneous pneumomediastinum associated with COVID-19: Rare complication of 2020 pandemic. J Pulmonol Respir Res. 2020: doi: 10.29328/journal.jprr.1001016; 4: 018-020

Read More

Most Viewed

Read More

Help ?